News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,125 Results
Type
Article (48572)
Company Profile (284)
Press Release (702255)
Multimedia
Podcasts (119)
Webinars (20)
Section
Business (211077)
Career Advice (2594)
Deals (36438)
Drug Delivery (131)
Drug Development (84187)
Employer Resources (186)
FDA (17012)
Job Trends (15506)
News (358239)
Policy (34377)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2793)
Accelerated approval (38)
Adcomms (30)
Allergies (154)
Alliances (52826)
ALS (185)
Alzheimer's disease (1731)
Antibody-drug conjugate (ADC) (352)
Approvals (17255)
Artificial intelligence (583)
Autoimmune disease (173)
Automation (46)
Bankruptcy (376)
Best Places to Work (12007)
BIOSECURE Act (22)
Biosimilars (201)
Biotechnology (182)
Bladder cancer (169)
Brain cancer (64)
Breast cancer (662)
Cancer (5100)
Cardiovascular disease (429)
Career advice (2185)
Career pathing (42)
CAR-T (302)
CDC (61)
Celiac Disease (2)
Cell therapy (801)
Cervical cancer (38)
Clinical research (71875)
Collaboration (1873)
Company closure (4)
Compensation (1184)
Complete response letters (63)
COVID-19 (2847)
CRISPR (101)
C-suite (920)
Cystic fibrosis (149)
Data (6503)
Decentralized trials (2)
Denatured (39)
Depression (146)
Diabetes (537)
Diagnostics (6942)
Digital health (50)
Diversity (13)
Diversity, equity & inclusion (48)
Drug discovery (278)
Drug pricing (209)
Drug shortages (31)
Duchenne muscular dystrophy (250)
Earnings (91068)
Editorial (64)
Employer branding (22)
Employer resources (164)
Events (119891)
Executive appointments (1029)
FDA (20273)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (24)
Funding (1561)
Gene editing (215)
Generative AI (49)
Gene therapy (655)
GLP-1 (1053)
Government (4987)
Grass and pollen (7)
Guidances (385)
Healthcare (19684)
HIV (72)
Huntington's disease (49)
IgA nephropathy (85)
Immunology and inflammation (278)
Immuno-oncology (71)
Indications (127)
Infectious disease (3147)
Inflammatory bowel disease (206)
Inflation Reduction Act (15)
Influenza (127)
Intellectual property (266)
Interviews (441)
IPO (16877)
IRA (55)
Job creations (3835)
Job search strategy (1815)
JPM (60)
Kidney cancer (18)
Labor market (88)
Layoffs (576)
Leadership (42)
Legal (8412)
Liver cancer (96)
Longevity (18)
Lung cancer (688)
Lymphoma (390)
Machine learning (47)
Management (64)
Manufacturing (857)
MASH (175)
Medical device (14269)
Medtech (14330)
Mergers & acquisitions (20644)
Metabolic disorders (1372)
mRNA (174)
Multiple sclerosis (172)
NASH (23)
Neurodegenerative disease (346)
Neuropsychiatric disorders (101)
Neuroscience (3066)
Neurotech (1)
NextGen: Class of 2026 (6870)
Non-profit (4780)
Now hiring (69)
Obesity (651)
Opinion (310)
Ovarian cancer (171)
Pain (217)
Pancreatic cancer (240)
Parkinson's disease (297)
Partnered (37)
Patents (522)
Patient recruitment (533)
Peanut (60)
People (60800)
Pharmaceutical (69)
Pharmacy benefit managers (33)
Phase 1 (22395)
Phase 2 (31594)
Phase 3 (23534)
Pipeline (5851)
Policy (325)
Postmarket research (2727)
Preclinical (9500)
Press Release (68)
Prostate cancer (259)
Psychedelics (53)
Radiopharmaceuticals (292)
Rare diseases (929)
Real estate (6207)
Recruiting (74)
Regulatory (25717)
Reports (55)
Research institute (2551)
Resumes & cover letters (430)
Rett syndrome (29)
RNA editing (19)
RSV (85)
Schizophrenia (159)
Series A (263)
Series B (199)
Service/supplier (11)
Sickle cell disease (105)
Special edition (26)
Spinal muscular atrophy (165)
Sponsored (46)
Startups (3795)
State (2)
Stomach cancer (20)
Supply chain (111)
Tariffs (93)
The Weekly (78)
Vaccines (1100)
Venture capital (91)
Weight loss (431)
Women's health (100)
Worklife (22)
Date
Today (41)
Last 7 days (897)
Last 30 days (2840)
Last 365 days (30693)
2026 (5003)
2025 (31014)
2024 (36009)
2023 (40932)
2022 (52115)
2021 (56728)
2020 (55510)
2019 (48394)
2018 (36554)
2017 (33413)
2016 (32996)
2015 (38952)
2014 (32760)
2013 (27898)
2012 (30093)
2011 (30767)
2010 (29050)
Location
Africa (856)
Alabama (87)
Alaska (7)
Arizona (322)
Arkansas (15)
Asia (41516)
Australia (6927)
California (11739)
Canada (3399)
China (1154)
Colorado (496)
Connecticut (502)
Delaware (345)
Europe (91908)
Florida (1759)
Georgia (385)
Hawaii (3)
Idaho (63)
Illinois (907)
India (72)
Indiana (554)
Iowa (22)
Japan (448)
Kansas (130)
Kentucky (44)
Louisiana (27)
Maine (81)
Maryland (1449)
Massachusetts (8441)
Michigan (339)
Minnesota (653)
Mississippi (6)
Missouri (130)
Montana (32)
Nebraska (29)
Nevada (127)
New Hampshire (83)
New Jersey (3111)
New Mexico (31)
New York (3102)
North Carolina (1530)
North Dakota (9)
Northern California (5753)
Ohio (357)
Oklahoma (22)
Oregon (41)
Pennsylvania (2357)
Puerto Rico (24)
Rhode Island (49)
South America (1223)
South Carolina (69)
South Dakota (1)
Southern California (4580)
Tennessee (181)
Texas (1819)
United States (41741)
Utah (358)
Vermont (1)
Virginia (274)
Washington D.C. (83)
Washington State (958)
West Virginia (4)
Wisconsin (116)
Wyoming (2)
751,125 Results for "quintilesims quintiles inc merged with ims".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development
January 7, 2026
·
5 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Press Releases
ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
February 4, 2026
·
7 min read
Press Releases
AleraCare and PURE Healthcare Announce Intent to Merge
August 14, 2025
·
3 min read
Press Releases
Evestia Clinical to merge with Atlantic Research Group
July 16, 2025
·
5 min read
Press Releases
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025
September 18, 2025
·
3 min read
Press Releases
BioSig Enters into an LOI to Merge with Streamex Exchange Corp.
May 6, 2025
·
4 min read
Press Releases
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
February 10, 2026
·
4 min read
Press Releases
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
August 18, 2025
·
7 min read
Press Releases
2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment
September 19, 2025
·
8 min read
1 of 75,113
Next
